
==== Front
BMJBMJBMJ-UKbmjThe BMJ0959-81381756-1833BMJ Publishing Group Ltd. correction123410.1136/bmj.l2365CorrectionsExposing drug industry funding of UK patient organisations 2019 03 6 2019 03 6 2019 365 l2365Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions2019BMJThis is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
==== Body
The “Who received funding?” section of this analysis by Ozieranski and colleagues (BMJ 2019;365:l1806, doi:10.1136/bmj.l1906) contains a typographical error. It should read that “Most funding (£47 466 806, 82.8%) went to 314 multipurpose organisations . . .” rather than 31.

